CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 05, 2024	Oct. 07, 2023
Cash flows from operating activities
Net earnings	$ 35,380	$ 41,932
Adjustments to reconcile net earnings to net cash provided by operating activities:
Non-cash restructuring, asset impairment, and other charges	16,129	1,273
Depreciation and amortization	78,147	75,245
Non-cash rent	(2,437)	(2,760)
LIFO expense	5,046	22,445
Postretirement benefits income	(969)	(1,990)
Deferred income taxes	9,634	11,388
Stock-based compensation expense	8,052	9,960
Stock warrant	700	1,279
(Gain) loss on disposals of assets	(48)	304
Other operating activities	1,388	1,308
Changes in operating assets and liabilities:
Accounts receivable	(66,080)	(23,071)
Inventories	16,634	(32,688)
Prepaid expenses and other assets	(12,055)	(3,558)
Accounts payable	55,136	37,517
Accrued payroll and benefits	(15,529)	(34,960)
Current income taxes	(7,893)	(3,564)
Other accrued expenses and other liabilities	2,020	(4,380)
Net cash provided by operating activities	123,255	95,680
Cash flows from investing activities
Purchases of property and equipment	(97,867)	(86,212)
Net proceeds from the sale of assets	2,058	4,055
Acquisitions, net of cash acquired	(14,370)	(780)
Loans to customers	(1,305)	0
Payments from customers on loans	1,372	1,097
Other investing activities	(540)	(163)
Net cash used in investing activities	(110,652)	(82,003)
Cash flows from financing activities
Proceeds from senior secured credit facility	1,011,564	1,044,242
Payments on senior secured credit facility	(974,969)	(1,017,484)
Repayment of other long-term debt and finance lease liabilities	(8,014)	(6,279)
Share repurchases	(15,051)	(18,527)
Net payments related to stock-based award activities	(3,196)	(3,977)
Dividends paid	(22,635)	(22,381)
Other financing activities	(756)	(803)
Net cash used in financing activities	(13,057)	(25,209)
Net decrease in cash and cash equivalents	(454)	(11,532)
Cash and cash equivalents at beginning of period	17,964	29,086
Cash and cash equivalents at end of period	$ 17,510	$ 17,554